Items where Author is "Shoushtari, M. H."
 | Up a level |
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 2.
Article
(2024) Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial. Frontiers in Immunology. p. 10. ISSN 1664-3224
(2021) Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia. International Immunopharmacology. ISSN 1567-5769